Health CareJury: Gilead Owes Merck $200M In Damages Over Drug PatentsMarch 25, 2016(AP) — The federal jury in a high-stakes patent trial ordered drugmaker Gilead to pay rival Merck $200 million in damages for infringing on patents for hepatitis C drugs.
Health CareBrown's Budget Proposal Allocates Millions For Hepatitis C DrugsJanuary 12, 2015 | Pauline BartoloneCalifornia Governor Jerry Brown is setting aside hundreds of millions of dollars in next year’s state budget to pay for high-cost drugs, mostly to treat Hepatitis C. Listen /Update RequiredTo play audio, update browser or Flash plugin.
